Blood Reviews
Volume 23, Issue 2 , Pages 49-59 , March 2009

Vitamin K deficiency bleeding (VKDB) in early infancy

References 

  1. Townsend CW. The haemorrhagic disease of the new-born. Arch Pediatr. 1894;11:559–565
  2. Hathaway WE. Vitamin K deficiency in the newborn: historical perspectives, diagnosis, and prevention. In:  Shearer MJ,  Seghatchian MJ editor. Vitamin K-dependent proteins: analytical, physiological and clinical aspects. Boca Raton: CRC Press; 1993;p. 229–244
  3. Sutor AH, von Kries R, Cornelissen EAM, McNinich AW, Andrew M. ISTH Pediatric/Perinatal Subcommittee International Society on Thrombosis and Haemostasis. Vitamin K deficiency bleeding (VKDB) in infancy. Thromb Haemost. 1999;81:456–461
  4. Loughnan PM, McDougall PN. Epidemiology of late onset haemorrhagic disease: a pooled data analysis. J Paediatr Child Health. 1993;29:177–181
  5. Newman P, Shearer MJ. Vitamin K metabolism. Subcell Biochem. 1998;30:455–488
  6. Salomonsen L. On the prevention of hemorrhagic disease of the new-born by the administration of cow’s milk during the first two days of life. Acta Paediatr. 1940;28:1–7
  7. Dam H, Glavind J, Larsen EH, Plum P. Investigations into the cause of the physiological hypoprothrombinemia in newborn children IV. The vitamin K content of woman’s milk and cow’s milk. Acta Med Scand. 1942;112:210–216
  8. American Academy of Pediatrics. Committee statement, Committee on Nutrition. Vitamin K supplementation for infants receiving milk substitute infant formulas and those with fat malabsorption. Pediatrics 1971;48:483–7.
  9. Haroon Y, Shearer MJ, Rahim S, Gunn WG, McEnery G, Barkhan P. The content of phylloquinone (vitamin K1) in human milk, cows’ milk and infant formula foods determined by high-performance liquid chromatography. J Nutr. 1982;112:1105–1117
  10. Indyk HE, Woollard DC. Vitamin K in milk and infant formulas: determination and distribution of phylloquinone and menaquinone-4. Analyst. 1997;122:465–469
  11. Thijssen HHW, Drittij M-J, Vermeer C, Schoffelen E. Menaquinone-4 in breast milk is derived from dietary phylloquinone. Brit J Nutr. 2002;87:219–226
  12. von Kries R, Shearer M, McCarthy PT, Haug M, Harzer G, Göbel U. Vitamin K1 content of maternal milk: influence of stage of lactation, lipid composition, and vitamin K1 supplements given to the mother. Pediatr Res. 1987;22:513–517
  13. Greer FR, Marshall S, Cherry J, Suttie JW. Vitamin K status of lactating mothers, human milk, and breast-feeding infants. Pediatrics. 1991;88:751–756
  14. Suttie JW. Vitamin K and human nutrition. J Am Diet Assoc. 1992;92:585–590
  15. Widdershoven J, van Muster P, De Abreu R, et al. Four methods compared for measuring des-carboxy-prothrombin (PIVKA-II). Clin Chem. 1987;33:2074–2078
  16. Motohara K, Endo F, Matsuda I. Effect of vitamin K administration on acarboxy prothrombin (PIVKA-II) levels in newborns. Lancet. 1985;2:242–244
  17. Clarke P, Mitchell SJ, Wynn R, et al. Vitamin K prophylaxis for preterm infants: a randomized, controlled trial of 3 regimens. Pediatrics. 2006;118:e1657–e1666
  18. Usui Y, Tanimura H, Nishimura N, Kobayashi N, Okanoue T, Ozawa K. Vitamin K concentrations in the plasma and liver of surgical patients. Am J Clin Nutr. 1990;51:846–852
  19. Andrew M. The relevance of developmental hemostasis to hemorrhagic disorders of newborns. Semin Perinatol. 1997;21:70–85
  20. Aballi AJ, de Lamerens S. Coagulation changes in the neonatal period and in early infancy. Pediatr Clin North Am. 1962;9:785–817
  21. van Doorm JM, Muller AD, Hemker HC. Heparin-like inhibitor, not vitamin K deficiency, in the newborn. Lancet (letter). 1977;1:852–853
  22. von Kries R, Becker A, Göbel U. Vitamin K in the newborn: influence of nutritional factors on acarboxy-prothrombin detectability and factor II and VII clotting activity. Eur J Pediatr. 1987;146:123–127
  23. Widdershoven J, Lambert W, Motohara K, et al. Plasma concentrations of vitamin K1 and PIVKA-II in bottle-fed and breast-fed infants with and without vitamin K prophylaxis at birth. Eur J Pediatr. 1988;148:139–142
  24. Motohara K, Endo F, Matsuda I. Vitamin K deficiency in breast-fed infants at one month of age. J Pediatr Gastroenterol Nutr. 1986;5:931–933
  25. Shearer MJ. Vitamin K metabolism and nutriture. Blood Reviews. 1992;6:92–104
  26. Suttie JW. The importance of menaquinones in human nutrition. Annu Rev Nutr. 1995;15:399–417
  27. Lane PA, Hathaway WE. Vitamin K in infancy. J Pediatr. 1985;106:351–359
  28. Motohara K, Matsukane I, Endo F, Kiyota Y, Matsuda I. Relationship of milk intake and vitamin K supplementation to vitamin K status in newborns. Pediatrics. 1989;84:90–93
  29. Hanawa Y, Maki M, Murata B, et al. The second nation-wide survey in Japan of vitamin K deficiency in infancy. Eur J Pediatr. 1988;147:472–477
  30. Chuansumrit A, Isarangkura P, Hathirat P, Vitamin K Study Group. Vitamin K deficiency bleeding in Thailand: a 32-year history. Southeast Asian J Trop Med Public Health 1998;29:649–54.
  31. McNinch AW, Orme RL’E, Tripp JH. Haemorrhagic disease of the newborn returns. Lancet. 1983;1:1089–1090
  32. von Kries R, Shearer MJ, Göbel U. Vitamin K in infancy. Eur J Pediatr. 1988;147:106–112
  33. von Kries R, Hachmeister A, Göbel U. Can 3 oral 2mg doses of vitamin K effectively prevent late vitamin K deficiency bleeding?. Eur J Pediatr. 1999;158:S183–S186
  34. Lulseged S. Haemorrhagic disease of the newborn: a review of 127 cases. Ann Trop Paediatr. 1993;13:331–336
  35. Sutherland JM, Glueck HI, Gleser G. Hemorrhagic disease of the newborn. Breast feeding as a necessary factor in the pathogenesis. Am J Dis Child. 1967;113:524–533
  36. Cornelissen M, von Kries R, Loughnan P, Schubiger G. Prevention of vitamin K deficiency bleeding: efficacy of different multiple oral dose schedules of vitamin K. Eur J Pediatr. 1997;156:126–130
  37. McNinch A, Busfield A, Tripp J. Vitamin K deficiency bleeding in Great Britain and Ireland: British Paediatric Surveillance Unit Surveys, 1993–1994 and 2001–2002. Arch Dis Child. 2007;92:759–766
  38. Monagle P, Barnes C, Ignjatovic V, et al. Developmental haemostasis. Impact for clinical haemostasis laboratories. Thromb Haemost. 2006;95:362–372
  39. Lippi G, Salvagno GL, Rugolotto S, et al. Routine coagulation tests in newborn and young infants. J Thromb Thrombolysis. 2007;24:153–155
  40. Keeling D. International Normalized Ratio in patients not on vitamin K antagonists. J Thromb Haemost. 2007;5:188–189
  41. Humpl T, Brühl K, Brzezinska R, Hafner G, Coerdt W, Shearer MJ. Fatal late vitamin K- deficiency bleeding after oral vitamin K-prophylaxis secondary to unrecognised bile duct paucity. J Pediatr Gastroenterol Nutr. 1999;29:594–597
  42. Rutty GN, Smith CM, Malia RG. Late-form hemorrhagic disease of the newborn: a fatal case report with illustration of investigations that may assist in avoiding the mistaken diagnosis of child abuse. Am J Forensic Med Pathol. 1999;20:48–51
  43. Paediatric Formulary Committee. BNF for children 2007. London: BMJ Publishing Group, RPS Publishing and RCPCH Publications; 2007.
  44. Sutor AH, Künzer W. Time interval between vitamin K administration and effective hemostasis. In:  Suzuki S,  Hathaway WE,  Bonnar J,  Sutor AH editor. Perinatal thrombosis and hemostasis. Tokyo: Springer-Verlag; 1991;p. 257–262
  45. Flood VH, Galderisi FC, Lowas SR, Kendrick A, Boshkov LK. Hemorrhagic disease of the newborn despite vitamin K prophylaxis at birth. Pediatr Blood Cancer. 2008;50:1075–1077
  46. van der Meer J, Hemker HC, Loeliger EA. Pharmacological aspects of vitamin K1: a clinical and experimental study in man. Thromb Diath Haemorrh. 1968;Suppl. 29:1–95
  47. Shah DV, Suttie JW. Vitamin K-dependent carboxylase: increased activity in a hypoprothrombinemia state. Arch Biochem Biophys. 1978;191:571–577
  48. Shah DV, Swanson JC, Suttie JW. Vitamin K-dependent carboxylase: effect of detergent concentrations, vitamin K status, and added protein precursors on activity. Arch Biochem Biophys. 1983;222:216–221
  49. Esmon CT, Grant GA, Suttie JW. Purification of an apparent rat liver prothrombin precursor: characterization and comparison to normal rat prothrombin. Biochemistry. 1975;14:1595–1600
  50. Furie B, Bouchard BA, Furie BC. Vitamin K-dependent biosynthesis of γ-carboxyglutamic acid. Blood. 1999;93:1798–1808
  51. Williams MD, Chalmers EA, Gibson BE. Haemostasis and Thrombosis Task Force, British Committee for Standards in Haematology. The investigation and management of neonatal haemostasis and thrombosis. Br J Haematol. 2002;119:295–309
  52. O’Shaughnessy DF, Atterbury C, Bolton Maggs P, et al. British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol. 2004;126:11–28
  53. Chalmers EA. Neonatal coagulation problems. Arch Dis Child Fetal Neonatal Ed. 2004;89:F475–F478
  54. Hubbard D, Tobias JD. Intracerebral hemorrhage due to hemorrhagic disease of the newborn and failure to administer vitamin K at birth. South Med J. 2006;99:1216–1220
  55. Clarke P, Shearer MJ. Vitamin K deficiency bleeding after missed prophylaxis: rapid synergistic effect of vitamin K therapy on hemostasis. South Med J. 2007;100:612–613
  56. McNinch AW, Tripp JH. Haemorrhagic disease of the newborn in the British Isles: two year prospective study. BMJ. 1991;303:1105–1109
  57. von Kries R, Hanawa Y. Neonatal vitamin K prophylaxis. Report of Scientific and Standardization Subcommittee on Perinatal Haemostasis. Thromb Haemost. 1993;69:293–295
  58. Keenan WJ, Jewett T, Glueck HI. Role of feeding and vitamin K in hypoprothrombinemia of the newborn. Am J Dis Child. 1971;121:271–277
  59. Choo KE, Tan KK, Chuah SP, Ariffin WA, Gururaj A. Haemorrhagic disease in newborn and older infants: a study in hospitalized children in Kelantan, Malaysia. Ann Trop Paediatr. 1994;14:231–237
  60. Ungchusak K, Tishyadhigama S, Choprapawon C, Sawadiwutipong W, Varintarawat S. Incidence of idiopathic vitamin K deficiency in infants: a national, hospital-based, survey in Thailand, 1983. J Med Assoc Thai. 1988;71:417–421
  61. Danielsson N, Hoa DP, Thang NV, Vos T, Loughnan PM. Intracranial haemorrhage due to late onset vitamin K deficiency bleeding in Hanoi province, Vietnam. Arch Dis Child Fetal Neonatal Ed. 2004;89:F546–F550
  62. American Academy of Pediatrics, Committee on Nutrition. Vitamin K compounds and the water-soluble analogues: use in therapy and prophylaxis in pediatrics. Pediatrics 1961;28:501–7.
  63. von Kries R. Oral versus intramuscular phytomenadione: safety and efficacy compared. Drug Safety. 1999;21:1–6
  64. Hanawa Y. Vitamin K deficiency in infancy: the Japanese experience. Acta Paediatr Jpn. 1992;34:107–116
  65. Hansen KN, Ebbesen F. Neonatal vitamin K prophylaxis in Denmark; three years’ experience with oral administration during the first three months of life compared with one oral administration at birth. Acta Paediatr. 1996;85:1137–1139
  66. Hansen KN, Minousis M, Ebbesen F. Weekly oral vitamin K prophylaxis in Denmark. Acta Paediatr. 2003;92:802–805
  67. Busfield A, McNinch A, Tripp J. Neonatal vitamin K prophylaxis in Great Britain and Ireland: the impact of perceived risk and product licensing on effectiveness. Arch Dis Child. 2007;92:754–758
  68. IJland MM, Pereira RR, Cornelissen EAM. Incidence of late vitamin K deficiency bleeding in newborns in the Netherlands in 2005: evaluation of the current guideline. Eur J Pediatr. 2008;167:165–169
  69. van Hasselt PM, de Koning TJ, Kvist N, et al. Prevention of vitamin K deficiency bleeding in breastfed infants: lessons from the Dutch and Danish biliary atresia registries. Pediatrics. 2008;121:e857–e863
  70. Clarke P, Shearer MJ. Vitamin K deficiency bleeding: the readiness is all. Arch Dis Child. 2007;92:741–743
  71. Pereira SP, Shearer MJ, Williams R, Mieli-Vergani G. Intestinal absorption of mixed micellar phylloquinone (vitamin K1) is unreliable in infants with conjugated hyperbilirubinaemia: implications for oral prophylaxis of vitamin K deficiency bleeding. Arch Dis Child Fetal Neonatal Ed. 2003;88:F113–F118
  72. von Kries R, Hachmeister A, Göbel U. Oral mixed micellar vitamin K for prevention of late vitamin K deficiency bleeding. Arch Dis Child Fetal Neonatal Ed. 2003;88:F109–F112
  73. Golding J, Paterson M, Kinlen LJ. Factors associated with childhood cancer in a national cohort study. Br J Cancer. 1990;62:304–308
  74. Golding J, Greenwood R, Birmingham K, Mott M. Childhood cancer, intramuscular vitamin K, and pethidine given during labour. BMJ. 1992;305:341–346
  75. Hull D. Vitamin K and childhood cancer: the risk of haemorrhagic disease is certain; that of cancer is not. BMJ. 1992;305:326–327
  76. Parker L, Cole M, Craft AW, Hey EN. Neonatal vitamin K administration and childhood cancer in the north of England: retrospective case-control study. BMJ. 1998;316:189–193
  77. IARC Monographs on the evaluation of carcinogenic risks to humans, vol. 76. Some antiviral and antineoplastic drugs, and other pharmaceutical agents. Vitamin K substances. Lyon: IARC Press; 2000;76:417–86.
  78. Roman E, Fear NT, Ansell P, et al. Vitamin K and childhood cancer: analysis of individual patient data from six case-control studies. Br J Cancer. 2002;86:63–69
  79. Fear NT, Roman E, Ansell E, Simpson J, Day N, Eden OB. United Kingdom Childhood Cancer Study Investigators. Vitamin K and childhood cancer: a report from the United Kingdom childhood cancer study. Br J Cancer. 2003;89:1228–1231
  80. Ross JA, Davies SM. Vitamin K prophylaxis and childhood cancer. Med Pediatr Oncol. 2000;34:434–437
  81. American Academy of Pediatrics Committee on Fetus and Newborn. Controversies concerning vitamin K and the newborn. Pediatrics 2003;112:191–2.
  82. Victora CG, van Haecke P. Vitamin K prophylaxis in less developed countries: policy issues and relevance to breastfeeding promotion. Am J Public Health. 1998;88:203–209
  83. Sharma RK, Marwaha N, Kumar P, Narang A. Effect of oral water soluble vitamin K on PIVKA-II levels in newborns. Indian Pediatr. 1995;32:863–867
  84. Ekelund H. Late haemorrhagic disease in Sweden 1987-89. Acta Paediatr Scand. 1991;80:966–968
  85. Tönz O, Schubiger G. Neonatale Vitamin K Prophylaxe und Vitamin-K-Mangelblutungen in der Schweitz 1986–1988. Schweitz Med Wochenschr. 1988;118:1747–1752
  86. von Kries R, Göbel U. Vitamin K prophylaxis and vitamin K deficiency bleeding (VKDB) in early infancy. Acta Paediatr. 1992;81:655–657

PII: S0268-960X(08)00052-0

doi: 10.1016/j.blre.2008.06.001

Blood Reviews
Volume 23, Issue 2 , Pages 49-59 , March 2009

Article Tools